Medical Condition News

RSS

Helicobacter pylori infection found to lower cognition among adults in the UK

Researchers evaluated the association between Helicobacter pylori and cognition.

9 Jun 2023

Impact of orally administered cannabidiol (CBD) on fitness and health among healthy adult individuals

Researchers evaluated the effects of oral CBD administration on the health and fitness of healthy adults.

9 Jun 2023

Mechanistic insights into how the SARS-CoV-2 virus affects the nervous system, alters its function, and causes neuropathology

Study demonstrates that SARS-CoV-2 infection and viral fusogens cause glial and neuronal fusion.

9 Jun 2023

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Researchers investigated the alveolar type II reparative response in COVID-19 pneumonia.

9 Jun 2023

Global trials could save lives by changing treatment procedure for cancer in the future

Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives by changing how we treat cancer in the near future.

9 Jun 2023

Exploring the viability of a new treatment for vascular dementia

Researchers from The University of Texas at El Paso's School of Pharmacy will explore the viability of a new treatment for vascular dementia, thanks to a $2.2 million grant from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS).

9 Jun 2023

MIS-C in children: A distinct autoimmune response to COVID-19 unveiled

The study reveals that MIS-C patients, post SARS-CoV-2 infection, develop a unique immune response against the virus' N protein, indicating a cross-reactivity with the self-protein SNX8, which might link the infection to the ensuing inflammatory syndrome.

8 Jun 2023

Gut health boost: Functional foods and herbs show promise in tackling SARS-CoV-2 variants

Functional foods and natural herbs have the potential to enhance immune function and maintain gut microbiota diversity. This review explores their role in mitigating the impact of SARS-CoV-2 variants on gut health and overall well-being.

8 Jun 2023

Two studies spotlight intestinal T cells that could be targeted to prevent resistance to ICB cancer therapy

Two new studies in Science and Science Immunology spotlight a group of intestinal T cells with α4β7 integrin receptors that could be targeted to prevent resistance to immune checkpoint blockade (ICB) cancer immunotherapy.

8 Jun 2023

Transient ischemic attack with incomplete neurovascular imaging linked to higher risk of subsequent stroke

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), transient ischemic attack (TIA) emergency department (ED) encounters with incomplete neurovascular imaging were associated with higher odds of subsequent stroke within 90 days.

8 Jun 2023

Preoperative stereotactic radiosurgery improves outcomes for patients with metastatic brain tumor

Cancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor.

8 Jun 2023

Study may help advance data on oncolytic adenovirus mediated double suicide-gene therapy for high-grade brain tumors

Researchers in the Hermelin Brain Tumor Center at Henry Ford Health are leading a Phase I clinical trial studying the maximum tolerated dose of an oncolytic adenovirus, a mutated virus engineered to selectively replicate in and destroy cancer tissue, in combination with fractionated stereotactic radiosurgery among patients who are undergoing resection of a recurrent high-grade astrocytoma brain tumor.

8 Jun 2023

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Insilico Medicine, a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM6331, a potential best-in-class pan-TEAD inhibitor, as a preclinical candidate compound (PCC) generated by Chemistry42, its proprietary generative chemistry-driven molecule design engine, targeting the Hippo pathway for the treatment of advanced solid tumors.

8 Jun 2023

Study shows how blood makes the brain’s immune cells toxic

In patients with neurological diseases like Alzheimer's disease and multiple sclerosis, immune cells in the brain known as microglia that normally fulfill beneficial functions become harmful to neurons, leading to cognitive dysfunction and motor impairment.

8 Jun 2023

First-in-class drug shows promise as a safe and effective treatment for cannabis use disorder

A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor shows promise as a safe and effective treatment for cannabis use disorder (CUD), a condition where a person is unable to control their cannabis use, even though it's causing problems in their lives.

8 Jun 2023

Experimental drug may slow the progression of atherosclerosis

An experimental drug already tested as a potential treatment for cancer, lung disease, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

8 Jun 2023

Study: Only 50% of athletes can identify sudden cardiac arrest or provide CPR

It is well known that early resuscitation with cardiopulmonary resuscitation (CPR) and an automated external defibrillator (AED) saves lives, and in most sports-related sudden cardiac arrest events, trainers or medical personnel respond and initiate protocols to resuscitate a player while other athletes standby.

8 Jun 2023

Weak spot discovery could pave way for more effective cancer therapies

1
2
3
4
...
5016
Next

Medical Condition News

Helicobacter pylori infection found to lower cognition among adults in the UK

Impact of orally administered cannabidiol (CBD) on fitness and health among healthy adult individuals

Mechanistic insights into how the SARS-CoV-2 virus affects the nervous system, alters its function, and causes neuropathology

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Global trials could save lives by changing treatment procedure for cancer in the future

Exploring the viability of a new treatment for vascular dementia

MIS-C in children: A distinct autoimmune response to COVID-19 unveiled

Gut health boost: Functional foods and herbs show promise in tackling SARS-CoV-2 variants

Two studies spotlight intestinal T cells that could be targeted to prevent resistance to ICB cancer therapy

Transient ischemic attack with incomplete neurovascular imaging linked to higher risk of subsequent stroke

Preoperative stereotactic radiosurgery improves outcomes for patients with metastatic brain tumor

Study may help advance data on oncolytic adenovirus mediated double suicide-gene therapy for high-grade brain tumors

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Study shows how blood makes the brain’s immune cells toxic

First-in-class drug shows promise as a safe and effective treatment for cannabis use disorder

Experimental drug may slow the progression of atherosclerosis

Study: Only 50% of athletes can identify sudden cardiac arrest or provide CPR

Weak spot discovery could pave way for more effective cancer therapies

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

UC research examines role of a metabolite in the development of abdominal aortic aneurysm

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News